Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein
H Mattock1, D P Lane, E Warbrick
1Department of Surgery and Molecular Oncology, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom.
Abstract:
p21 (WAF1/Cip1) is the only member of the CIP/KIP family which has a well-characterized PCNA-binding domain. p21 is known to have an important function in the coordination of the cellular pathways which are activated in response to DNA damage, though the significance of the p21-PCNA interaction is not completely clear. We have analyzed the effects of expressing a miniprotein containing the PCNA-binding domain of p21 upon the cell cycle and upon the proliferation of various cell types. We have compared this with the effect of expressing a mutant form which is defective in PCNA-binding, but which retains the secondary cyclin-CDK-inhibitory site. No PCNA-dependent effects were seen in the short term upon cell cycle distribution. However, clonogenic assays show that the GFP-peptide miniprotein can significantly suppress proliferation in a PCNA-dependent manner. In some cell types, however, the suppression of proliferation was not PCNA-dependent, suggesting that cellular environment is a contributory factor to the effect of this miniprotein. The capacity of this peptide sequence to suppress cell proliferation in vivo is of interest as the basis for the design of potential antiproliferative therapeutic agents.
Insights
The p21 protein
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p21 (WAF1/Cip1) is a key regulator in DNA damage response pathways.
- Its interaction with PCNA (Proliferating Cell Nuclear Antigen) is crucial but not fully understood.
- The PCNA-binding domain of p21 is essential for its function.
Purpose of the Study:
- To investigate the role of the p21-PCNA interaction in cell cycle regulation and proliferation.
- To evaluate the antiproliferative potential of a miniprotein mimicking the PCNA-binding domain of p21.
Main Methods:
- Expression of a miniprotein containing the PCNA-binding domain of p21.
- Comparison with a mutant miniprotein lacking PCNA-binding capacity.
- Analysis of cell cycle distribution and clonogenic assays for proliferation assessment.
Main Results:
- Short-term cell cycle distribution was unaffected by miniprotein expression.
- The PCNA-binding miniprotein significantly suppressed cell proliferation in a PCNA-dependent manner.
- Some cell types showed proliferation suppression independent of PCNA, indicating environmental influence.
Conclusions:
- The PCNA-binding domain of p21 plays a significant role in suppressing cell proliferation.
- The cellular environment influences the antiproliferative effects of the p21-derived miniprotein.
- This peptide sequence holds potential for developing novel antiproliferative therapeutics.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Inhibition of CDK Activity


